← Open Payments lookup

LIEN NGUYEN: Open Payments

NPI 1508906033 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,245 in 96 payments from 17 companies in 2025. Trend: 2023 $2,444 · 2024 $2,054 · 2025 $7,245

Speaker / faculty: $4,050Food & beverage: $3,195
CompanyPaymentsAmount
Janssen Biotech, Inc.12$4,381
Aimmune Therapeutics, Inc.20$795
Madrigal Pharmaceuticals7$567
ABBVIE INC.9$276
GENZYME CORPORATION8$258
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$207
Takeda Pharmaceuticals U.S.A., Inc.11$162
Medtronic, Inc.1$143
Lilly USA, LLC4$100
VIVUS LLC4$92

Products named: TREMFYA, ZENPEP, REZDIFFRA, DUPIXENT, XIFAXAN, CREON, BARRX, ENTYVIO.

Industry payments across CA — which companies pay providers there.